Document Detail

Risk of cardiovascular disease and all-cause mortality among diabetic patients prescribed rosiglitazone or pioglitazone: a meta-analysis of retrospective cohort studies.
MedLine Citation:
PMID:  23217404     Owner:  NLM     Status:  In-Data-Review    
BACKGROUND: The difference of cardiovascular effects between rosiglitazone and pioglitazone treatment for diabetic patients has not been thoroughly studied. We performed a meta-analysis to compare the risk of cardiovascular adverse effects in patients with type 2 diabetes treated with rosiglitazone compared to pioglitazone.
METHODS: The Cochrane Library, PubMed, and Embase were searched to identify retrospective cohort studies assessing cardiovascular outcomes with rosiglitazone and pioglitazone. Meta-analysis of retrospective cohort studies was conducted using RevMan 5.0 software to calculate risk ratios.
RESULTS: Of the 74 references identified, eight studies involving 945 286 patients fit the inclusion criteria for the analysis. The results of meta-analyses showed that, compared with pioglitazone, rosiglitazone therapy significantly increased the risk of myocardial infarction (risk ratios (RR) 1.17, 95% confidence interval (CI) 1.04 - 1.32; P = 0.01), the risk of heart failure (RR 1.18, 95%CI 1.02 - 1.36; P = 0.03), and total mortality (RR 1.13, 95%CI 1.08 - 1.20; P < 0.000 01).
CONCLUSION: Compared with pioglitazone, rosiglitazone was associated with an increased risk of myocardial infarction, heart failure, and all-cause mortality in diabetic patients.
Xin Chen; Li Yang; Suo-di Zhai
Related Documents :
23105824 - Dyslipidemia in pregnancy may contribute to increased risk of neural tube defects -a pi...
25059494 - Conditional inference trees: a method for predicting intimate partner violence.
24793554 - Comparison of homocysteinemia and mthfr 677ct polymorphism with framingham coronary hea...
21118054 - Understanding the influence of the snack definition on the association between snacking...
20205004 - Partner support and distress in women with breast cancer: the role of patients' awarene...
25336704 - Ovarian reserve screening: a scientific and ethical analysis.
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Chinese medical journal     Volume:  125     ISSN:  0366-6999     ISO Abbreviation:  Chin. Med. J.     Publication Date:  2012 Dec 
Date Detail:
Created Date:  2012-12-10     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  7513795     Medline TA:  Chin Med J (Engl)     Country:  China    
Other Details:
Languages:  eng     Pagination:  4301-6     Citation Subset:  IM    
Department of Pharmacy, Peking University Third Hospital, Beijing 100191, China.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Autologous bone marrow stem cell transplantation in critical limb ischemia: a meta-analysis of rando...
Next Document:  Extensive pneumocephalus extending into the lateral ventricles from a brain abscess: an intracranial...